|
Name |
Ophiobolin P
|
Molecular Formula | C25H36O4 | |
IUPAC Name* |
(1S,3R,6R,7S,9E,13R,15R,16R)-13,15-dihydroxy-3,15-dimethyl-6-[(2S,3Z)-6-methylhepta-3,5-dien-2-yl]-12-oxatetracyclo[8.5.1.03,7.013,16]hexadec-9-en-11-one
|
|
SMILES |
C[C@@H](/C=C\C=C(C)C)[C@H]1CC[C@]2([C@H]1C/C=C/3\[C@H]4[C@H](C2)[C@](C[C@]4(OC3=O)O)(C)O)C
|
|
InChI |
InChI=1S/C25H36O4/c1-15(2)7-6-8-16(3)17-11-12-23(4)13-20-21-18(9-10-19(17)23)22(26)29-25(21,28)14-24(20,5)27/h6-9,16-17,19-21,27-28H,10-14H2,1-5H3/b8-6-,18-9+/t16-,17+,19-,20-,21-,23+,24+,25+/m0/s1
|
|
InChIKey |
KNMOPFLBPXTWRO-UERVZAPGSA-N
|
|
Synonyms |
CHEMBL4171012; Ophiobolin P; BDBM50523086
|
|
CAS | NA | |
PubChem CID | 73388106 | |
ChEMBL ID | CHEMBL4171012 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 400.5 | ALogp: | 5.1 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 4 |
Heavy Atoms: | 29 | QED Weighted: | 0.516 |
Caco-2 Permeability: | -4.632 | MDCK Permeability: | 0.00001970 |
Pgp-inhibitor: | 0.997 | Pgp-substrate: | 0.009 |
Human Intestinal Absorption (HIA): | 0.179 | 20% Bioavailability (F20%): | 0.942 |
30% Bioavailability (F30%): | 0.939 |
Blood-Brain-Barrier Penetration (BBB): | 0.062 | Plasma Protein Binding (PPB): | 97.11% |
Volume Distribution (VD): | 1.973 | Fu: | 2.37% |
CYP1A2-inhibitor: | 0.096 | CYP1A2-substrate: | 0.549 |
CYP2C19-inhibitor: | 0.605 | CYP2C19-substrate: | 0.846 |
CYP2C9-inhibitor: | 0.784 | CYP2C9-substrate: | 0.086 |
CYP2D6-inhibitor: | 0.386 | CYP2D6-substrate: | 0.084 |
CYP3A4-inhibitor: | 0.932 | CYP3A4-substrate: | 0.578 |
Clearance (CL): | 9.425 | Half-life (T1/2): | 0.293 |
hERG Blockers: | 0.312 | Human Hepatotoxicity (H-HT): | 0.626 |
Drug-inuced Liver Injury (DILI): | 0.387 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.039 | Maximum Recommended Daily Dose: | 0.93 |
Skin Sensitization: | 0.966 | Carcinogencity: | 0.07 |
Eye Corrosion: | 0.026 | Eye Irritation: | 0.431 |
Respiratory Toxicity: | 0.945 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003783 | 0.632 | D0P0HT | 0.269 | ||||
ENC002000 | 0.632 | D0I2SD | 0.267 | ||||
ENC005803 | 0.530 | D04GJN | 0.256 | ||||
ENC003251 | 0.515 | D0L2LS | 0.252 | ||||
ENC005047 | 0.463 | D06AEO | 0.250 | ||||
ENC003687 | 0.459 | D0Q6NZ | 0.250 | ||||
ENC002981 | 0.389 | D04SFH | 0.246 | ||||
ENC004491 | 0.383 | D0B4RU | 0.243 | ||||
ENC003209 | 0.371 | D0K0EK | 0.243 | ||||
ENC003777 | 0.368 | D0KR5B | 0.240 |